Leadership Team

We expect the highest standard of excellence in all that we do and have chosen the right people to lead the way

Comprised of talented individuals from all over the world, NZP's leadership team are renowned in the industry for their knowledge and experience. The team know that our performance is a pivotal to the success of our customers. That allows us to deliver the quality product that our valued clients have come to expect.

ANDY LEWIS - Chief Executive Officer

Andy joined NZP in April 2005 as General Manager, responsible for overall management & administration of the company, global procurement of key raw materials and key client management.
In September 2009, Andy oversaw the acquisition of UK subsidiary (Dextra). In March 2010, Andy was appointed to the role of CEO of the company’s three subsidiaries, and is a Director on the company’s Board. Prior to NZP, Andy gained experience managing a number of manufacturing companies across Asia-Pacific, leading business mergers & transitions.
Andy holds a BSc, and MBA (Massey University) and is a Member of the NZ Institute of Directors.

MIKE IRONSIDE - Chief Strategic Officer

Dr Mike Ironside joined NZP in April 2017 in the role of Chief Strategic Officer. He is responsible for planning, leading and executing the company’s strategic growth objectives on a global scale, ensuring the effective delivery of the commercialisation of our major projects into sustainable ongoing business. Mike will also focus on supporting our commercial, contractual and market development functions for our current priority products, and ongoing bile acid research and development programmes.
Mike holds a BSc in Organic Chemistry and a PhD in Synthetic Chemistry. He has 20+ years of experience in a range of senior CMC and commercial leadership roles within the global pharmaceutical industry, helping advance novel pharmaceutical candidates along the development spectrum from pre-clinical evaluation towards commercialisation.

ED TEECE - General Manager, NZP

Ed joined NZP in April 2010 as Operations Manager. Ed has a wealth of global experience in the Pharmaceutical Industry, spanning over 20 years, in a variety of functions including Site Operations, Manufacturing (Finished Dosage Forms and API), Quality Operations, Project Management and R&D. Ed is a Chartered Chemist and Fellow of the Royal Society of Chemistry (CChem FRSC), Chartered Quality Professional (CQP CQI), holds an MSc in Industrial Pharmacy from the University of Manchester, is an experienced EU Qualified Person (Commercial and IMP) with eligibility for nomination under the permanent provisions, and a Member of the NZ Institute of Directors (MInstD).

KAREN ETHERINGTON - General Manager, Dextra & NZPUK

Karen joined Dextra in 2006 to manage the analytical and quality functions at the Reading site. Having worked for the WHO, been instrumental in the founding and expansion of Warwick Analytical Service, the head of Analytical Chemistry at Ultrafine and SAFC in Manchester she has significant experience in the research, development, manufacturing, quality and regulatory activities related to the production of active pharmaceutical ingredients.

ALEX WEYMOUTH-WILSON - Chief Scientific Officer

Alex completed his graduate and postgraduate education at the University of Reading receiving his PhD in 1993 under the supervision of Professor John Mann. With over 20 years experience in the fine chemical industry at Dextra, Isochem and CMS, Alex has extensive synthetic experience developing innovative scalable routes to key intermediates and API's predominately in the field of carbohydrates. Alex was appointed Chief Scientific Officer of Dextra and NZP in 2011.